El
Eliem Therapeutics
Redmond WAFounded 201930 employees
Private CapbiotechAcquiredCNS
Platform: Pain Channel
Market Cap
N/A
All Drugs
3
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Datorasimod | ELI-8500 | NDA/BLA | 1 | FGFR | T2DPancreatic Ca | ||
| Talalucimab | ELI-3128 | Preclinical | 1 | B7-H3 | SCLC | ||
| ELI-3182 | ELI-3182 | Preclinical | 1 | PLK4 | IPFAS |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)